Aesthetic device leadership Quantificare and its spin-off Quartier Latin position themselves as leaders in aesthetic imaging, demonstrated by multiple Best Aesthetic Device awards and a dedicated market focus. This presents a sales opportunity to partner with dermatology clinics, cosmetic manufacturers, and medi-spas seeking proven imaging solutions and co-development potential.
Patent and IP leverage Active patent enforcement against Canfield Scientific and ongoing UPC proceedings indicate a strong IP position in imaging technology. This creates a door for sales conversations around licensed technology, exclusive features, and potential collaboration or procurement deals that emphasize protected, cutting-edge imaging capabilities.
Global expansion Launch of Quartier Latin in France signals appetite for international growth and cross-border support. Opportunities exist to sell expanded service capabilities, international trial management, and multi-region imaging solutions for global pharma and cosmetic clients requiring standardized imaging across sites.
Cloud and automation Introduction of LifeViz Neo Cloud Software with AI-enhanced automation and secure data sharing presents a recurring revenue stream and upsell path for existing clients transitioning off legacy contracts. Target clinics and CROs needing scalable, compliant data workflows and enhanced collaboration should be engaged.
Award-winning credibility Consistent industry recognition for best aesthetic devices reinforces trust and shortening sales cycles. Leverage awards and case studies to approach potential customers in the cosmetic, dermatology, and clinical trial spaces who prioritize proven performance and peer-validated imaging solutions.